Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000079275 | SCV000050756 | likely benign | not provided | 2013-06-24 | criteria provided, single submitter | research | |
Eurofins Ntd Llc |
RCV000173030 | SCV000111145 | likely benign | not specified | 2014-07-16 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001082290 | SCV000218722 | benign | Long QT syndrome | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000622244 | SCV000735199 | benign | Cardiovascular phenotype | 2015-09-04 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Mendelics | RCV000306251 | SCV001138622 | benign | Timothy syndrome | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000079275 | SCV001890790 | benign | not provided | 2018-11-28 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 26498160) |
ARUP Laboratories, |
RCV000079275 | SCV002049935 | likely benign | not provided | 2023-10-10 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002498393 | SCV002809049 | likely benign | Timothy syndrome; Brugada syndrome 3; Long qt syndrome 8 | 2022-04-11 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000079275 | SCV003916801 | likely benign | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing | CACNA1C: PP2, PP3, BS1, BS2 |
Prevention |
RCV003944997 | SCV004774048 | likely benign | CACNA1C-related disorder | 2019-09-09 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Clinical Genetics, |
RCV000173030 | SCV001919553 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000173030 | SCV001927830 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000173030 | SCV001954118 | benign | not specified | no assertion criteria provided | clinical testing |